m.Stock by Mirae AssetOpen Demat Account
m.Stock by Mirae Asset

IPO Accretion Pharmaceuticals Ltd

  • Price Range

    ₹96 - ₹101

  • Min. Quantity

    1,200

  • Closes on

    16 May 2025

  • Min. investment

    ₹1,21,200/1,200 Shares

Accretion Pharmaceuticals Ltd IPO Timeline

Accretion Pharmaceuticals was incorporated in year 2012, the Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, to provide health care products. Thus, the foundation of 'Accretion Pharmaceuticals' was laid down, which was started as a Partnership Firm in the name of 'M/s Accretion Pharmaceuticals', pursuant to a deed of partnership dated December 18, 2012.

EventDate
Accretion Pharmaceuticals Ltd IPO Opening Date14 May 2025
Accretion Pharmaceuticals Ltd IPO Closing Date 16 May 2025
Basis of Allotment19 May 2025
Initiation of Refunds20 May 2025
Credit of Shares to Demat20 May 2025
Accretion Pharmaceuticals Ltd IPO Listing Date21 May 2025

Accretion Pharmaceuticals Ltd IPO Details

Accretion Pharmaceuticals Ltd IPO Date14 May 2025 to 16 May 2025
Accretion Pharmaceuticals Ltd IPO Face Value10 per share
Accretion Pharmaceuticals Ltd IPO Price96 to ₹101 per share
Accretion Pharmaceuticals Ltd IPO Lot Size1,200
Issue SizeShares of ₹10 (aggregating up to ₹28.28 Cr)
Fresh IssueShares of ₹10 (aggregating up to ₹29.75 Cr)
Offer for Sale-
Issue TypeBook Building - SME
Listing At NSE - SME
QIB Shares Offered-
Retail Shares Offered-
NII (HNI) Shares Offered-
Company PromotersHarshad Nanubhai Rathod, Vivek Ashok Kumar Patel, Mayur Popatlal Sojitra

Accretion Pharmaceuticals Ltd IPO Lot Size

The Accretion Pharmaceuticals Ltd IPO lot size is 1,200 shares. A retail-individual investor can apply for up to 1 lots (1,200 shares or ₹1,21,200).

Application LotsSharesAmount
Minimum11,200₹1,21,200
Maximum11,200₹1,21,200
  • Risks
  • Opportunities
  • Experienced Promoters and Management Team.
  • Consistently supplying quality products to our valued customers in time.
  • Continually improving the quality standards by implementing process control and prevention techniques.
  • Long-standing relationship with clients and suppliers.
  • Quality standards.
  • Legacy Business Process & Management.
  • Strong and experienced R&D team.

Company Financials

Accretion Pharmaceuticals Ltd Financial Information (Restated)

Period Ended Total AssetsTotal RevenueProfit After Tax
03-202426.8713.411.49
Amount in ₹ Crore

Objects of the Issue

The company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:

  • Capital expenditure towards purchase of new equipment/machineries, etc
  • Capital expenditure towards upgradation of existing mfg facility
  • Expenditure in connection with product registration in overseas market
  • Repayment/prepayment of certain borrowings availed by the company
  • Funding working capital requiremnts
  • General corporate purposes

Accretion Pharmaceuticals Ltd IPO Promoter Holding

Pre Issue Share Holding24.07%
Post Issue Share Holding17.61%

Accretion Pharmaceuticals Ltd IPO Subscription Status (Bidding Detail)

The Accretion Pharmaceuticals Ltd IPO is subscribed 0 times on 16 May 2025 05:00:00 PM. The public issue subscribed 0 times in the retail category, 0 times in the QIB category, and 0 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategoryQIBNIIRetailEmployeeTotal
Subscription (times)-----

Accretion Pharmaceuticals Ltd IPO Prospectus

Accretion Pharmaceuticals Ltd IPO Listing Date

Listing Date21 May 2025
BSE Script -
NSE Symbol-
Listing In NSE - SME
ISININE0T8T01010
IPO Price0
Face Value10

Company Contact Information

Accretion Pharmaceuticals Ltd
29 Xcelon Ind Park 1Vasna Chacharvadi Sanand,Ahmedabad-382213
Phone: +91 97148 82929
Email: care@accretionpharma.com
Website: http://www.accretionpharma.com

Accretion Pharmaceuticals Ltd IPO Registrar

Phone:+91-40-6716 2222/
Email: apl.ipo@kfintech.com
Website: www.kfintech.com

Accretion Pharmaceuticals Ltd IPO Lead Manager(s)

  1. Jawa Capital Services Pvt Ltd

FAQ

What is the issue size of Accretion Pharmaceuticals Ltd IPO?

Accretion Pharmaceuticals Ltd IPO, which opens for subscription from to 16 May 2025 has an issue size of ₹28.28 crore. The issue type is book building issue.

I have pre-applied for Accretion Pharmaceuticals Ltd IPO. When will my order get placed?

In case of pre-apply, your IPO order will be placed on the Exchange as soon as the official bidding for TBI Corn Ltd IPO begins. You will receive a UPI request within 24 hours after the bidding period opens.

What are the open and close dates for Accretion Pharmaceuticals Ltd IPO?

Accretion Pharmaceuticals Ltd IPO Opens for subscription from 14 May 2025 to 16 May 2025

What is the lot size and minimum order quantity of the Accretion Pharmaceuticals Ltd IPO?

The lot size of Accretion Pharmaceuticals Ltd is 1,200 shares. Retail investors can subscribe to minimum 1 lot and maximum 1 lots. The minimum and maximum application value is ₹1,21,200 and ₹1,21,200 respectively.

What are the allotment dates for the Accretion Pharmaceuticals Ltd IPO?

Allotment date for Accretion Pharmaceuticals Ltd is 19 May 2025 and refund of application amount (in case allotment is not received) will begin from 20 May 2025. If your allotment goes through, then shares will be credited in your Demat account by 20 May 2025.

Who is the registrar of Accretion Pharmaceuticals Ltd IPO?

The registrar for Accretion Pharmaceuticals Ltd IPO is KFin Techologies Ltd . You can check your IPO allotment status on the registrar's website.

Where is the Accretion Pharmaceuticals Ltd IPO getting listed?

The shares of Accretion Pharmaceuticals Ltd are proposed to be listed on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE)